Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Encompass HealthMEX:EHC 79 Days Payable is 298.48 as of Jun. 2026, which is 28% above its 10-year median of 232.36. GuruFocus rates MEX:EHC with a GF Score™ of 79/100 and a GF Value™ of MXN1,437.19 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Encompass Health ranks better than 88.32% on this metric.
The historical rank and industry rank for Encompass Health's Days Payable or its related term are showing as below:
MEX:EHC'
s Days Payable Range Over the Past 10 Years
Min: 169.33 Med: 232.36 Max: 260.39
Current: 257.88
During the past 13 years, Encompass Health's highest Days Payable was 260.39. The lowest was 169.33. And the median was 232.36.
MEX:EHC's Days Payable is ranked better than 88.32% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 56.91
vs MEX:EHC: 257.88
Encompass Health's Days Payable
increased
from Jun. 2025 (251.16) to Jun. 2026 (298.48).
It may suggest that Encompass Healthdelayed paying its suppliers.
The historical data trend for Encompass Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:EHC vs ENSG, UHS, PACS: Days Payable Comparison
For the Medical Care Facilities subindustry, Encompass Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Encompass Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Encompass Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Encompass Health (MEX:EHC) has a Days Payable of 298.48 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Encompass Health and its competitors. This is 28% above median its historical median of 232.36. Over the past decade, Encompass Health's Days Payable has ranged from 169.33 to 260.39. According to the industry distribution chart, Encompass Health ranks #71 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 11.7%.
Is Encompass Health's Days Payable too high?
Encompass Health's current Days Payable of 298.48 is 28% above median its 10-year median of 232.36. Over the past 10 years, this metric has ranged from a low of 169.33 to a high of 260.39. The Healthcare Providers & Services industry median Days Payable is 56.91. Encompass Health's value of 298.48 is 424.5% above this industry median. Based on the distribution chart, Encompass Health ranks #71 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Encompass Health has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's Days Payable compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #71 out of 608 companies for Days Payable. This places Encompass Health in the top 12% of its industry — outperforming the majority of peers. The industry median Days Payable is 56.91. Encompass Health's value of 298.48 is 424.5% above this benchmark. Historically, Encompass Health's own Days Payable has ranged from 169.33 to 260.39 over the past decade. While the company's 10-year median is 232.36 vs. the industry median of 56.91, Encompass Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.91, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current Days Payable of 298.48 is 424.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current Days Payable is 298.48, which is 28% above median its own 10-year median of 232.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Based on GuruFocus' analysis, Encompass Health (MEX:EHC) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,437.19, compared to a current price of MXN1,920.00 — trading 33.6% above its estimated fair value. The current Days Payable is 298.48, which is 28% above median its 10-year median of 232.36 and 424.5% above the Healthcare Providers & Services industry median of 56.91. Encompass Health's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current Days Payable is 298.48 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be overvalued.
The current stock price of MXN1,920.00 is trading 33.6% above its estimated GF Value™ of MXN1,437.19.
GuruFocus considers Encompass Health to be Significantly Overvalued.
Key valuation signals for MEX:EHC:
Days Payable: 298.48 (28% above median its 10-year median of 232.36)
GF Value™: MXN1,437.19 vs. price of MXN1,920.00 (33.6% above fair value)
Industry Position: 424.5% above the Healthcare Providers & Services median (#71 of 608)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
79GF Score
Get the complete analysis for MEX:EHC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
